Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.52%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
6.85 Down 0.16(2.28%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 13,034   7,823   6,856   18,452  
Cost of Revenue -   -   -   -  
Gross Profit 13,034   7,823   6,856   18,452  
Operating Expenses
Research Development30,324  30,055  37,630  42,465  
Selling General and Administrative6,224  6,010  5,150  5,095  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (23,514) (28,242) (35,924) (29,108)
Income from Continuing Operations
Total Other Income/Expenses Net271  373  107  150  
Earnings Before Interest And Taxes(23,243)(27,869)(35,817)(28,958)
Interest Expense4,511  4,479  3,946  1,293  
Income Before Tax(27,754)(32,348)(39,763)(30,251)
Income Tax Expense -   -   -   -  
Minority Interest169  (711)132  169  
Net Income From Continuing Ops(27,585)(33,059)(39,631)(30,082)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (27,585) (33,059) (39,631) (30,082)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (27,585) (33,059) (39,631) (30,082)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.